Foresee Genomics is developing a decentralized next-generation sequencing (NGS) platform designed to bring advanced molecular diagnostics into small and mid-sized clinical laboratories. Today, most genomic testing is centralized in large reference labs, creating long turnaround times, high costs, and limited access for community-based providers. This represents a significant market gap, as thousands of smaller laboratories lack the infrastructure to offer in-house molecular testing. Foresee addresses this gap with a fully integrated solution combining targeted sequencing panels, optimized wet-lab workflows, and a local bioinformatics pipeline, enabling laboratories to run high-quality genomic tests with minimal infrastructure and expertise.